Piper Sandler raised the firm’s price target on GE HealthCare (GEHC) to $94 from $91 and keeps an Overweight rating on the shares. The firm believes the Q4 setup tilts positive after shares have pulled back in recent weeks on Flyrcado guidance uncertainty.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Buy/Sell: Wall Street’s top 10 stock calls this week
- GE HealthCare Stock (GEHC) Slips after Catching a Downgrade
- Nvidia initiated, DraftKings upgraded: Wall Street’s top analyst calls
- GE HealthCare downgraded to Sell from Neutral at UBS
- GE HealthCare price target raised to $98 from $86 at Goldman Sachs